Brind.

Scott Young has been appointed Vice President, Investor Relations at Xilio Therapeutics.

1 report, 0 independent Updated Jul 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Scott Young has been appointed Vice President, Investor Relations at Xilio Therapeutics.

Who's involved

What this event is mainly about
Xilio Therapeutics (United States)Scott Young

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet